Report overview
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia.High blood sugar is caused by defective secretion of insulin or impaired biological function, or both.Long-term hyperglycemia leads to chronic damage and dysfunction of various tissues, especially eyes, kidneys, heart, blood vessels and nerves.
This report aims to provide a comprehensive presentation of the global market for Diabetes Mellitus Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Mellitus Drugs. This report contains market size and forecasts of Diabetes Mellitus Drugs in global, including the following market information:
Global Diabetes Mellitus Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Diabetes Mellitus Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oral Medicine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Diabetes Mellitus Drugs include Novo Nordisk, Merck & Co, Boehringer Ingelheim, AstraZeneca, Eli Lilly and Company, Johnson & Johnson, Takeda, Sanofi and Gan & Lee Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetes Mellitus Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Mellitus Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Diabetes Mellitus Drugs Market Segment Percentages, by Type, 2022 (%)
Oral Medicine
Injection Medicine
Global Diabetes Mellitus Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Diabetes Mellitus Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Diabetes Mellitus Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Diabetes Mellitus Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Mellitus Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Diabetes Mellitus Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Merck & Co
Boehringer Ingelheim
AstraZeneca
Eli Lilly and Company
Johnson & Johnson
Takeda
Sanofi
Gan & Lee Pharmaceuticals
Bayer
Tonghua Dongbao Pharmaceutical Co
Huadong Medicine
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetes Mellitus Drugs, market overview.
Chapter 2: Global Diabetes Mellitus Drugs market size in revenue.
Chapter 3: Detailed analysis of Diabetes Mellitus Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetes Mellitus Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
